Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus

Background: Functional polymorphisms of the solute carrier family 22, member 4 (SLC22A4), runt related transcription factor 1 (RUNX1) and small ubiquitin-like modifier 4 (SUMO-4) genes have been shown to be associated with several autoimmune diseases. Objective: To test the possible role of these va...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2006
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22345
Acceso en línea:
https://doi.org/10.1136/ard.2005.044891
https://repository.urosario.edu.co/handle/10336/22345
Palabra clave:
Membrane protein
Protein slc22a4
Sumo protein
Transcription factor runx1
Unclassified drug
Adult
Allele
Article
Autoimmune disease
Colombia
Controlled study
Disease severity
Gene linkage disequilibrium
Genetic susceptibility
Genotype
Human
Major clinical study
Nephritis
Priority journal
Single nucleotide polymorphism
Spain
Sweden
Systemic lupus erythematosus
Adult
Alleles
Case-control studies
Chi-square distribution
Core binding factor alpha 2 subunit
Female
Genetic predisposition to disease
Genotype
Humans
Male
Middle aged
Odds ratio
Organic cation transport proteins
Small ubiquitin-related modifier proteins
systemic
genetic
Lupus erythematosus
Polymorphism
Rights
License
Abierto (Texto Completo)
Description
Summary:Background: Functional polymorphisms of the solute carrier family 22, member 4 (SLC22A4), runt related transcription factor 1 (RUNX1) and small ubiquitin-like modifier 4 (SUMO-4) genes have been shown to be associated with several autoimmune diseases. Objective: To test the possible role of these variants in susceptibility to or severity of systemic lupus erythematosus (SLE), on the basis that common genetic bases are shared by autoimmune disorders. Methods: 597 SLE patients and 987 healthy controls of white Spanish origin were studied. Two additional cohorts of 228 SLE patients from Sweden and 122 SLE patients from Colombia were included. A case-control association study was carried out with six single nucleotide polymorphisms (SNP) spanning the SLC22A4 gene, one SNP in RUNX1 gene, and one additional SNP in SUM04 gene. Results: No significant differences were observed between SLE patients and healthy controls when comparing the distribution of the genotypes or alleles of any of the SLC22A4, RUNX1, or SUMO4 polymorphisms tested. Significant differences were found in the distribution of the SUMO4 genotypes and alleles among SLE patients with and without nephritis, but after multiple testing correction, the significance of the association was lost. The association of SUMO4 with nephritis could not be verified in two independent SLE cohorts from Sweden and Colombia. Conclusions: These results suggest that the SLC22A4, RUNX1, and SUMO4 polymorphisms analysed do not play a role in the susceptibility to or severity of SLE.